AlphaQuest’s Cardlytics CDLX Stock Holding History

AlphaQuest’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,796	Closed	-$147K	–	1894
2024 Q2	$147K	Buy	1,796 +1,106	+160%	+$120K	0.02%	841
2024 Q1	$99.9K	Buy	+690	New	+$58.3K	0.02%	819

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

BCM

Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AlphaQuest's CDLX Position: Q3 2024 in Review

AlphaQuest sold out of Cardlytics (CDLX) in Q3 2024, closing a stake of 1,796 shares — an estimated $147K sold.

AlphaQuest first reported a position in CDLX in Q1 2024 and held it in 2 quarters. The position peaked at $147K in Q2 2024. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.

AlphaQuest reported no remaining Cardlytics position as of Q3 2024 after selling out during the quarter.
AlphaQuest sold 1,796 Cardlytics shares in Q3 2024, an estimated $147K.
AlphaQuest first reported a position in Cardlytics in Q1 2024 and held it in 2 quarters.
AlphaQuest's Cardlytics position peaked at $147K in Q2 2024.
111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.

Based on AlphaQuest's 13F filing for Q3 2024, filed 7 Nov 2024.